John Wiedemann

John Wiedemann is a seasoned professional with over 20 years of experience in the pharmaceutical and biotech industry, specializing in marketing operations and the entire product life cycle.

His expertise includes developing and implementing various critical services such as reimbursement HUB services, Patient Assistance Programs, call center operations, co-pay programs, specialty pharmacy networks & distribution, and operations development for product launches.

John has a robust background in leading start-up operations, sales, product and brand strategy management, commercial & government managed markets, and executing marketing campaigns in various platforms.

He is known for his collaborative leadership style, working across functions to navigate complexities, ensuring alignment between strategy and execution.

With therapeutic expertise in specialty, rare disease, orphan drugs, and mass markets, John's experience spans across multiple segments including CNS, Plasma Bio-therapeutics, Diabetes, Cardiology, Oncology, and more.

John Wiedemann holds a BA in Political Science from Ohio Northern University and attended Marion Harding High School.

He has held significant roles in reputable organizations including Director, Patient Experience and Support Services at Travere Therapeutics, Associate Director roles at ACADIA Pharmaceuticals Inc. and CSL Behring, and various management positions at AstraZeneca, Chase, and other companies.

Throughout his career, he has excelled in roles such as Brand Manager, Business Planning Manager, President of JCW Consulting, and Founding Member and Partner at The John Maxwell Team.

His diverse experience encompasses areas such as National Accounts and Alliances, Brand Planning, Life-Cycle Management, Professional Sales, and Business Development.

John Wiedemann's professional journey includes a mix of strategic leadership, operational expertise, and a deep understanding of diverse market segments in the pharmaceutical and biotech industry.